Veyong Pharma participated in the 89th China International Pharmaceutical API Exhibition

On October 18, the 89th China International Pharmaceutical API Exhibition was grandly held at the Nanjing International Expo Center. Li Jianjie, General Manager of Veyong Pharma, Li Jieqing, Deputy General Manager and General Manager of the International Marketing Center, and Technology Research and Development of Limin Holding Group Nie Fengqiu, deputy director of the Synthesis R&D Laboratory of the Central Research Institute and director of the Veterinary Drug Preparation Laboratory, and Zhou Zhongfang, assistant to the general manager and marketing manager of Veyong Pharmaceutical, and others participated in the meeting, gathering together with many outstanding companies to innovate, cooperate, and find vitality!

During the exhibition, Sun Jingquan, director of the Research Institute of Limin Holdings Technology R&D Center, visited the Veyong Pharmaceutical exhibition area, visited Veyong Pharmaceutical’s API series products, and expressed his gratitude to all those who participated in the exhibition. Accompanied by a group of people, Mr. Sun visited a number of pharmaceutical groups and companies such as Livzon Group, Hisun Pharmaceuticals, Borui Pharmaceuticals, and Terra Animal Health, to understand the trends, trends and specific varieties of new animal research and development, as well as the joint application for new veterinary drugs, and gave instructions on the company’s next key product research and development plans, technical research projects, and product supporting projects with New Veyong. It is necessary to make full use of the group’s advantages, unify coordination, and promote all aspects of work. The smooth implementation of product innovation, technology research and development, pilot testing, large-scale production and technical transformation projects will provide sustained and long-term source of power for the further development of the group in the future.

On the third day of the exhibition, there were still crowds of people. The visitors were very enthusiastic and lively. The Veyong Pharma exhibition hall attracted many domestic and foreign customers to stop to inquire and communicate. With the professionalism of the sales team, they enthusiastically and patiently introduced the company to the customers one by one. Product quality and R&D advantages, we also have an in-depth understanding of customer needs, discussed the current market situation, and gained another group of new friends!

Relying on the group’s advantages, Veyong Pharmaceutical has always adhered to the development strategy of integrating raw materials and preparations to cope with market challenges and achieve steady and long-term development.